Home | Welcome to Contract Pharma   
Last Updated Sunday, March 29 2015


Hovione, Solvias in Solubility Pact

Published November 28, 2012
Related Searches: Development GMP Phase I Drug Delivery
Hovione and Solvias have entered a collaboration to develop and supply GMP pharmaceutical co-crystals, with the goal of overcoming poor bioavailability and other drug delivery challenges. Hovione will employ its particle engineering technologies to supply GMP materials from Phase I to commercial scale. Solvias will provide access to its co-crystallization expertise and capabilities.
“We are delighted to announce this collaboration with Solvias increasing the breadth of drug delivery solutions through our Particle Design offering. Solvias has a tremendous reputation for science, quality and expertise in crystal design for improved drug performance. This agreement reinforces our strategy of combining strengths with innovative companies to allow our customers a seamless and integrated approach to their drug delivery challenges.” said Dr. Colin Minchom, Hovione’s vice president of Particle Design.
Dr. Martina Diekmann, Solvias’ global head of business development analytics, said, “Solvias is delighted to work with Hovione. In establishing this agreement with Hovione, we are able to generate added value for our customers and to help them solving their drug delivery requirements.”

blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On